Medication access through patient assistant programs

American Journal of Health-System Pharmacy

Volumn 63, Issue 13, 2006, Pages 1254-1259

  Chauncey, Danielle ^a   Mullins, C Daniel ^a   Tran, Bac V ^b   McNally, Diane ^c   McEwan, Robert N ^d  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^b NERA ECONOMIC CONSULTING   (United States)

^c UMSP

^d MEDBANK of Maryland Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALAT CC; ADVAIR DISKUS; ALENDRONIC ACID; ALLEGRA D; AMFEBUTAMONE; AMLODIPINE; AMLODIPINE BESYLATE; AMLODIPINE PLUS BENAZEPRIL; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ARMOUR THYROID; ATENOLOL; ATOMOXETINE; ATORVASTATIN; AUGMENTIN XR; AVALIDE; AZITHROMYCIN; BENAZEPRIL; BETAMETHASONE DIPROPIONATE; BUDESONIDE; CARVEDILOL; CEFALEXIN; CEFDINIR; CEFPROZIL; CELECOXIB; CETIRIZINE; CIPROFLOXACIN; CITALOPRAM; CLARITHROMYCIN; CLONAZEPAM; CLOPIDOGREL; CONJUGATED ESTROGEN; CYCLOBENZAPRINE; DEPAKOTE ER; DESRYL; DEXAMETHASONE PLUS TOBRAMYCIN; DEXTROPROPOXYPHENE; DIAZEPAM; DIGOXIN; DILTIAZEM; DONEPEZIL; DORZOLAMIDE PLUS TIMOLOL; DOXYCYCLINE HYCLATE; ESCITALOPRAM; ESOMEPRAZOLE; EZETIMIBE; FELODIPINE; FENOFIBRATE; FENTANYL; FEXOFENADINE; FINASTERIDE; FLUCONAZOLE; FLUINDOSTATIN; FLUOXETINE; FLUTICASONE PROPIONATE; FOSINOPRIL; FUROSEMIDE; GABAPENTIN; GATIFLOXACIN; GEMFIBROZIL; GLIBENCLAMIDE; GLIBENCLAMIDE PLUS METFORMIN; GLIMEPIRIDE; GLIPIZIDE; GLYCERYL TRINITRATE; HYDROCHLOROTHIAZIDE PLUS LOSARTAN; HYDROCHLOROTHIAZIDE PLUS TRIAMTERENE; HYDROCHLOROTHIAZIDE PLUS VALSARTAN; HYDROXYZINE; INSULIN GLARGINE; INSULIN LISPRO; IRBESARTAN; ISOPHANE INSULIN; ISOSORBIDE 5 NITRATE; KLOR CON; LAMOTRIGINE; LANSOPRAZOLE; LATANOPROST; LESCOL XL; LEVOFLOXACIN; LEVOTHYROXINE; LEVOTHYROXINE SODIUM; LISINOPRIL; LOSARTAN POTASSIUM; MACROGOL 3350; MECLOZINE; MELOXICAM; METFORMIN; METOPROLOL; METOPROLOL SUCCINATE; MIRTAZAPINE; MOMETASONE FUROATE; MONTELUKAST; MOXIFLOXACIN; NAPROXEN; NASOCORT AQ; NICOTINIC ACID; NIFEDIPINE; NITROFURANTOIN; OLANZAPINE; OMEPRAZOLE; OXCARBAZEPINE; OXYBUTYNIN; PANTOPRAZOLE; PARACETAMOL PLUS TRAMADOL; PAROXETINE; PHENYTOIN; PIMECROLIMUS; PIOGLITAZONE; POTASSIUM CHLORIDE; PRAVASTATIN; PRINIZIDE; PROMETHAZINE; PROPRANOLOL; PSEUDOMONIC ACID; QUETIAPINE; QUINAPRIL; RABEPRAZOLE; RALOXIFENE; RANITIDINE; RHINOCORT AQ; RISEDRONIC ACID; RISPERIDONE; ROFECOXIB; ROSIGLITAZONE; SALBUTAMOL; SALCATONIN; SERTRALINE; SILDENAFIL; SIMVASTATIN; SUMATRIPTAN SUCCINATE; TAMSULOSIN; TERBINAFINE; TOLTERODINE; TOPIRAMATE; TRAMADOL; TUSSIONEX; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALACICLOVIR; VALPROATE SEMISODIUM; VALSARTAN; VENLAFAXINE; VERAPAMIL; WARFARIN;

DOCUMENTATION; DRUG COST; DRUG INDUSTRY; HEALTH CARE ACCESS; HEALTH CARE FINANCING; HEALTH CARE ORGANIZATION; HEALTH PROGRAM; HUMAN; INCOME; INTERNET; PRESCRIPTION; PRIORITY JOURNAL; REVIEW;

EID: 33745766216     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp050457     Document Type: Review

References (22)

1. Kaiser Family Foundation. Prescription drug trends, www.kff.org/ insurance/upload/3057-04.pdf (accessed 2004 Oct).
2. Schur CL, Doty MM, Berk ML. Lack of prescription coverage among the under 65: a symptom of underinsurance. Issue Brief (Commonw Fund). 2004; 716:1-8.
3. Cunningham PJ. Affording prescription drugs: not just a problem for the elderly. Center for Studying Health System Change. http://hschange.org/CONTENT/ 430/?Words=not+just+problem+for+ elderly (accessed 2004 Oct).
4. Tseng CW, Brook RH, Keeler E et al. Cost-lowering strategies used by Medicare beneficiaries who exceed drug benefit caps and have a gap in drug coverage. JAMA. 2004; 292:952-60.
5. Taylor H, Leitman R, eds. Out-of-pocket costs are a substantial barrier to prescription drug compliance, www. harrisinteractive.com/news/newsletters/ healthnews/HI_HealthCareNews 2001Vol1_iss32.pdf (accessed 2005 Feb 10).
6. Federman AD, Adams AS, Ross-Degnan D et al. Supplemental insurance and use of effective cardiovascular drugs among elderly Medicare beneficiaries with coronary heart disease. JAMA. 2001; 286:1732-9.
7. Reichert S, Simon T, Halm EA. Physicians' atitudes about prescribing and knowledge of the costs of common medications. Arch Intern Med. 2000; 160:2799-803.
8. Piette JD, Heisler M, Wagner TH. Cost-related medication underuse: do patients with chronic illnesses tell their doctors? Arch Intern Med. 2004; 164:1749-55.
9. Alexander GC, Casalino LP, Tseng CW et al. Barriers to patient-physician communication about out-of-pocket costs. J Gen Intern Med. 2004; 19:856-60.
10. Alexander GC, Casalino LP, Meltzer DO. Patient-physician communication about out-of-pocket costs. JAMA. 2003; 290:953-8.
11. Chisholm MA, DiPiro JT. Pharmaceutical manufacturer assistance programs. Arch Intern Med. 2002; 162:780-4.
12. Pharmaceutical Research and Manufacturers of America. Directory of prescription drug Patient Assistance Programs 2003-2004. www.HelpingPatients.org (accessed 2005 Feb 1).
13. Torres MC, Herman D, Montano S et al. Pharmacy assistance programs in a community health center setting. J Natl Med Assoc. 2002; 94:1077-86.
14. Sarrafizadeh M, Waite NM, Hobson EH et al. Pharmacist-facilitated enrollment in medication assistance programs in a private ambulatory care clinic. Am J Health-Syst Pharm. 2004; 61:1816-20.
15. Weiner S, Dischler J, Horvitz C. Beyond pharmaceutical manufacturer assistance: broadening the scope of an indigent drug program. Am J Health-Syst Pharm. 2001; 58:146-50.
16. Prutting SM, Mazur JN, Johnson CB et al. Evaluation of outcomes for patients enrolled in pharmaceutical assistance programs. Paper presented at ASHP Midyear Clinical Meeting. New Orleans, LA; 2003 Dec.
17. MEDBANK of Maryland. Inc. www. medbankmd.org (accessed 2005 Feb 1).
18. RxList. The top 200 prescriptions for 2003 by number of US prescriptions dispensed. www.RxList.com (accessed 2005 Jan 30).
19. RxHope. www.RxHope.com (accessed 2005 Dec 5).
20. RxAssist. www.RxAssist.org (accessed 2005 Dec 5).
21. Partnership for Prescription Assistance. www.PPARx.org (accessed 2005 Dec 5).
22. Department of Health and Human Services. Office of Inspector General (OIG). Publication of OIG special advisory bulletin on patient assistance programs for Medicare Part D enrollees. Fed Regist. 2005; 70:70623.